Skip to main content

Table 1 Clinical and pathologic information of training set, testing set and entire set

From: Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer

 

Training set

Testing set

Entire set

Character

NUMBER

%

NUMBER

%

NUMBER

%

Age

     

Median

65

64.5

65

Range

35–88

39–81

35–88

Os (m)

   

Median

15.5

15.9

15.6

Range

1.0–76.2

3.2–91.4

1.0–91.4

Status

 Alive

57

49.14

19

38.00

76

45.78

 Dead

59

50.86

31

62.00

90

54.22

Gender

 Male

65

56.03

25

50.00

90

54.22

 Female

51

43.97

25

50.00

76

45.78

AJCC_Stage

 I

12

10.35

6

12.00

18

10.84

 II

102

87.93

39

78.00

141

84.94

 III

1

0.86

2

4.00

3

1.81

 IV

1

0.86

3

6.00

4

2.41

Grade

 G1

17

14.66

9

18.00

26

15.66

 G2

63

54.31

28

56.00

91

54.82

 G3

34

29.31

13

26.00

47

28.31

 G4

2

1.72

0

0.00

2

1.21

T stage

 T1

4

3.45

2

4.00

6

3.61

 T2

16

13.79

5

10.00

21

12.65

 T3

95

81.90

41

82.00

136

81.93

 T4

1

0.86

2

4.00

3

1.81

N stage

 N0

31

26.72

14

28.00

45

27.11

 N1

84

72.42

34

68.00

118

71.08

 Nx

1

0.86

2

4.00

3

1.81

M stage

 M0

59

50.86

17

34.00

76

45.78

 M1

1

0.86

3

6.00

4

2.41

 MX

56

48.28

30

60.00

86

51.81